Profil
Currently, Beth Shafer is Director at Aquinnah Pharmaceuticals, Inc. and Venture Partner at Mubadala Capital Ventures Europe.
Formerly, Dr. Shafer was Director at Arcellx, Inc., Chief Business Officer at Voyager Therapeutics, Inc. from 2023 to 2024, and Chief Business Officer at Scholar Rock Holding Corp.
from 2024 to 2025.
Education includes a doctorate from the University of California, graduate studies at Columbia University Vagelos College of Physicians & Surgeons, and undergraduate studies at Rutgers University, Camden.
Postes actifs de Beth Shafer
| Sociétés | Poste | Début |
|---|---|---|
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development to modulate neurodegenerative stress granules | Directeur/Membre du Conseil | - |
Anciens postes connus de Beth Shafer
| Sociétés | Poste | Fin |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Corporate Officer/Principal | 01/05/2025 |
| VOYAGER THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2024 |
| ARCELLX, INC. | Directeur/Membre du Conseil | - |
Formation de Beth Shafer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Aquinnah Pharmaceuticals, Inc.
Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development to modulate neurodegenerative stress granules | Health Technology |
Rutgers University, Camden
Rutgers University, Camden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcellx, Inc.
Arcellx, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies | Health Technology |
Scholar Rock Holding Corp.
Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Columbia University Vagelos College of Physicians & Surgeons
Columbia University Vagelos College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















